Episode Details

Back to Episodes

SGEM#522: Va-so-Pressors – Can You Run Them Peripherally?

Published 1 month, 2 weeks ago
Description
Date: September 30, 2026  Dr. Aaron Skolnik Guest Skeptic: Dr. Aaron Skolnik is an Assistant Professor of Emergency Medicine at the Mayo Clinic Alix School of Medicine and Vice Chair of Critical Care Medicine at Mayo Clinic Arizona. Aaron is a full-time multidisciplinary intensivist and is the medical student clerkship director for critical care. Reference: ZhangJian et al. Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2026 Case: A 72-year-old woman presents by EMS with fever, productive cough, confusion and progressive weakness. Her temperature is 39.2°C, HR 118 beats/min, RR 28 breaths/min, oxygen saturation 91% on room air and BP 78/44 mmHg. She has coarse crackles over the right lower lung field and cool extremities. Chest radiography demonstrates a right lower-lobe infiltrate. Her lactate is 4.1 mmol/L. You establish two ultrasound-guided 18-gauge peripheral IVs, administer appropriate antibiotics and begin judicious crystalloid resuscitation. Her blood pressure remains 82/46 mmHg with a MAP of 58 mmHg. The nurse asks: “Do you want me to start the norepinephrine through the peripheral IV while you put in the central line?” Background: Shock is one of those diagnoses where time matters. At its core, shock is inadequate cellular oxygen utilization, resulting in tissue hypoperfusion. If left unchecked, this process leads to organ dysfunction, cardiovascular collapse, and death. For many of our patients, fluids alone will not restore adequate perfusion, and that is where vasopressors come in. They increase vascular tone and blood pressure, with norepinephrine generally being our first-line vasopressor in distributive/septic shock. Traditionally, we were taught that vasopressors belong in a central venous catheter (CVC). The rationale makes physiologic sense. These are potent vasoconstrictors, and extravasation into surrounding tissue could theoretically produce local ischemia, tissue necrosis, or even limb-threatening injury. A catheter sitting in a large central vein provides rapid dilution of the medication and avoids the small peripheral vessels where infiltration might cause trouble. The problem is that central lines are not benign and certainly aren’t instantaneous, as portrayed on TV shows. Placement takes time, equipment, expertise, and often ultrasound guidance. Complications include arterial puncture, bleeding, pneumothorax, arrhythmia, venous thrombosis, and catheter-related bloodstream infection. Meanwhile, the patient’s MAP is still circling the drain. The alternative is sitting right there in the patient’s arm: a peripheral IV that may already be functioning. Starting norepinephrine through that line allows us to treat the shock now and sort out longer-term vascular access later. The 2021 Surviving Sepsis Campaign reflected this shift by recommending initiation of vasopressors peripherally rather than delaying therapy until central access is obtained. That brings us to the bedside tension. We don’t want to delay a potentially life-saving drug while waiting for the perfect vascular access (perfect is the enemy of good). However, we also don’t want norepinephrine to infiltrate into someone’s forearm. The relevant question isn’t whether peripheral vasopressors are perfectly safe, because nothing we do in emergency medicine is perfectly safe. It is about how often clinically important adverse events occur, under what circumstances, and whether peripheral administration can spare patients the need for an invasive central line. You could say we are under a lot of pressure to make the right decision. Previous systematic reviews suggested that complications from peripheral vasopressors were uncommon and predominantly minor. However, those reviews had important gaps, including limited agent-specific information, relatively little information about midline catheters, and limited data addressing whether peripheral administration avoids
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us